These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38198547)

  • 1. TDP-43 impairs sleep in
    Perlegos AE; Durkin J; Belfer SJ; Rodriguez A; Shcherbakova O; Park K; Luong J; Bonini NM; Kayser MS
    Sci Adv; 2024 Jan; 10(2):eadj4457. PubMed ID: 38198547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS).
    Nihei Y; Ito D; Suzuki N
    J Biol Chem; 2012 Nov; 287(49):41310-23. PubMed ID: 23048034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes.
    Satterfield TF; Pallanck LJ
    Hum Mol Genet; 2006 Aug; 15(16):2523-32. PubMed ID: 16835262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins.
    Zeballos C MA; Moore HJ; Smith TJ; Powell JE; Ahsan NS; Zhang S; Gaj T
    Nat Commun; 2023 Oct; 14(1):6492. PubMed ID: 37838698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.
    He F; Krans A; Freibaum BD; Taylor JP; Todd PK
    Hum Mol Genet; 2014 Oct; 23(19):5036-51. PubMed ID: 24920338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.
    Matsukawa K; Hashimoto T; Matsumoto T; Ihara R; Chihara T; Miura M; Wakabayashi T; Iwatsubo T
    J Biol Chem; 2016 Nov; 291(45):23464-23476. PubMed ID: 27634045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span.
    Wang JW; Brent JR; Tomlinson A; Shneider NA; McCabe BD
    J Clin Invest; 2011 Oct; 121(10):4118-26. PubMed ID: 21881207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of Motor Defects Caused by Loss of
    Lembke KM; Scudder C; Morton DB
    J Neurosci; 2017 Sep; 37(39):9486-9497. PubMed ID: 28847811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
    Ito D
    Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LSM12 and ME31B/DDX6 Define Distinct Modes of Posttranscriptional Regulation by ATAXIN-2 Protein Complex in Drosophila Circadian Pacemaker Neurons.
    Lee J; Yoo E; Lee H; Park K; Hur JH; Lim C
    Mol Cell; 2017 Apr; 66(1):129-140.e7. PubMed ID: 28388438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion.
    Xia Q; Wang H; Hao Z; Fu C; Hu Q; Gao F; Ren H; Chen D; Han J; Ying Z; Wang G
    EMBO J; 2016 Jan; 35(2):121-42. PubMed ID: 26702100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAR DNA-binding protein 43 oligomers in physiology and pathology.
    Lye YS; Chen YR
    IUBMB Life; 2022 Aug; 74(8):794-811. PubMed ID: 35229461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.
    Kim HJ; Raphael AR; LaDow ES; McGurk L; Weber RA; Trojanowski JQ; Lee VM; Finkbeiner S; Gitler AD; Bonini NM
    Nat Genet; 2014 Feb; 46(2):152-60. PubMed ID: 24336168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
    Cheng CW; Lin MJ; Shen CK
    J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.
    Singh A; Hulsmeier J; Kandi AR; Pothapragada SS; Hillebrand J; Petrauskas A; Agrawal K; Rt K; Thiagarajan D; Jayaprakashappa D; VijayRaghavan K; Ramaswami M; Bakthavachalu B
    Elife; 2021 Mar; 10():. PubMed ID: 33689682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy.
    Lo Piccolo L; Umegawachi T; Yeewa R; Potikanond S; Nimlamool W; Prachayasittikul V; Gotoh Y; Yoshida H; Yamaguchi M; Jantrapirom S
    Neurotherapeutics; 2023 Sep; 20(5):1330-1346. PubMed ID: 37493896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
    Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
    Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
    MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.